Abiopharma

V2X and Elastic Partner to Strengthen Search and Agentic Analytics Across Government Mission Workflows

Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

Signing Day Sports and BlockchAIn Provide Update on Expected Ticker Symbol Transition and Common Stock Trading Schedule

Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

SiriusPoint Announces Creation of Global P&C Programs and London Market Specialty Divisions

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

Enlight Secures $304 Million in Project Financing for the Crimson Orchard Project in Idaho, USA

A Message from Our Chief Executive Officer

Almonty Completes Phase 1 of Sangdong Tungsten Mine in South Korea

Ferguson Files Definitive Proxy Materials and Transition Report

Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

HALEON PLC (HLN) Files Form 6-K

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices